Henan Cancer Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1977-01-01
- Employees
- -
- Market Cap
- -
Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors
Not yet recruiting
- Conditions
- Malignant Tumor
- Interventions
- Other: 3D printed bone prosthesis replacement surgery
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05616195
- Locations
- 🇨🇳
Department of Bone and Soft Tissue ,Henan Cancer Hospital, Zhengzhou, Henan, China
Cryoablation for Advanced Bone and Soft Tissue Tumors
Recruiting
- Conditions
- SarcomaCryoablation
- Interventions
- Procedure: Cryoablation
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05615545
- Locations
- 🇨🇳
Department of Bone and Soft Tissue ,Henan Cancer Hospital, Zhengzhou, Henan, China
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Phase 1
Not yet recruiting
- Conditions
- Gastroesophageal-junction CancerGastric Cancer
- Interventions
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT05608785
Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy
Not Applicable
Not yet recruiting
- Conditions
- ChemotherapyMalignant Tumor
- Interventions
- Other: Tik Tok
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT05598827
Application of Douyin in Perioperative Period of Malignant Tumor Patients
Not Applicable
Not yet recruiting
- Conditions
- Perioperative PeriodMalignant Tumor of Bone
- Interventions
- Other: Tik Tok
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT05598229
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
Recruiting
- Conditions
- AnxietyDepressionMalignant Tumor
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05596344
- Locations
- 🇨🇳
Department of Bone and Soft Tissue ,Henan Cancer Hospital, Zhengzhou, Henan, China
A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT05583383
- Locations
- 🇨🇳
Henan Tumor Hospital, Henan, China
Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma
Completed
- Conditions
- Esophagus Cancer
- Interventions
- Drug: Paclitaxel- and platinum-based chemotherapy
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 826
- Registration Number
- NCT05569668
- Locations
- 🇨🇳
Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou, Henan, China
Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung Cancer
Not yet recruiting
- Conditions
- NSCLC
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05547737
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence
Phase 2
Not yet recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Henan Cancer Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT05545124
© Copyright 2025. All Rights Reserved by MedPath